Strong Past Earnings Growth, P/E Ratio Below 20

Results

97

8 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

97 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	601601	CN¥29.63	-1.6%	-20.2%	CN¥269.9b	CN¥46.52	5.3	4.3%	3.9%	Insurance
	600031 New	CN¥17.77	0.1%	-2.1%	CN¥158.5b	CN¥25.98	19.3	23.1%	2.8%	Capital Goods
	600019	CN¥5.61	2.2%	-19.5%	CN¥118.4b	CN¥7.47	11.8	13.0%	6.4%	Materials
	605499	CN¥124.08	10.1%	-47.6%	CN¥90.1b	CN¥193.01	18.9	13.6%	3.1%	Food, Beverage & Tobacco
	002241 New	CN¥21.72	-8.9%	-8.4%	CN¥78.2b	CN¥31.90	19.2	6.2%	1.6%	Tech
	601168	CN¥27.33	-0.4%	55.5%	CN¥63.2b	CN¥33.60	14.7	13.6%	0.4%	Materials
	600066	CN¥27.51	3.5%	2.7%	CN¥62.3b	CN¥42.36	11.2	11.9%	9.1%	Capital Goods
	600233	CN¥17.93	15.3%	40.1%	CN¥59.3b	CN¥24.24	12.7	14.4%	1.4%	Transportation
	600415	CN¥10.38	2.8%	-44.3%	CN¥57.0b	CN¥22.02	13.0	18.7%	4.8%	Retail
	601061	CN¥11.20	-0.4%	37.3%	CN¥55.1b	n/a	15.7	n/a	1.8%	Capital Goods
	002236	CN¥16.51	-1.0%	3.9%	CN¥53.6b	CN¥22.52	13.7	12.1%	3.4%	Tech
	601607	CN¥15.92	0.9%	-10.9%	CN¥52.7b	CN¥20.65	10.2	5.2%	3.0%	Healthcare
	002532	CN¥10.93	-5.9%	23.6%	CN¥49.7b	CN¥23.74	8.4	17.8%	5.0%	Materials
	000933	CN¥21.17	-4.7%	22.4%	CN¥47.2b	CN¥37.86	8.5	15.3%	3.8%	Materials
	002555	CN¥19.57	3.2%	12.5%	CN¥42.2b	CN¥27.21	13.4	4.5%	5.3%	Media
	603979	CN¥61.70	-2.5%	31.6%	CN¥36.6b	CN¥80.95	15.3	20.7%	1.1%	Materials
	002517	CN¥16.47	2.5%	-13.8%	CN¥33.8b	CN¥27.77	16.1	15.1%	0.6%	Media
	000883	CN¥4.47	0.4%	-1.5%	CN¥31.4b	CN¥5.64	15.4	1.9%	3.4%	Utilities
	600801	CN¥16.46	-4.8%	30.1%	CN¥29.7b	CN¥24.03	10.5	10.9%	3.3%	Materials
	600295	CN¥11.51	5.2%	29.8%	CN¥29.2b	n/a	12.6	n/a	6.1%	Materials
	002432	CN¥67.16	-6.5%	83.5%	CN¥29.1b	n/a	12.3	n/a	2.5%	Healthcare
	600282	CN¥4.69	-0.6%	6.8%	CN¥28.9b	CN¥7.83	10.0	10.0%	5.5%	Materials
	600517	CN¥4.75	-3.5%	-6.7%	CN¥27.4b	n/a	11.7	n/a	2.8%	Capital Goods
	600079	CN¥17.22	3.6%	-20.3%	CN¥27.3b	n/a	14.8	n/a	2.8%	Pharmaceuticals & Biotech

Page 1 of 3